Monday, March 30, 2026

Could your brain cells make their own insulin? New research finds surprising link in human brain tissue.

Plain Language Summary
What this means for you:
Specific human brain cells can locally produce insulin and carry a diabetes drug receptor, hinting at a brain-based energy system.

We think of insulin as something made by the pancreas to control blood sugar. But what if your brain made its own? New research in human brain tissue reveals a surprising local connection. Scientists looked at specific types of calming brain cells, called interneurons, in the outer layer of the brain's cortex. They found that two particular subtypes—called neurogliaform and rosehip cells—were special. These cells not only carried the receptor for a common diabetes drug (GLP-1, like in Ozempic), but they also actively produced insulin messenger molecules right there in the brain. In the cells studied, the receptor was found in 44 out of 72 neurogliaform cells and 18 out of 36 rosehip cells. Insulin production was found in 29 and 11 of those same cell groups, respectively. Other similar calming cells showed no insulin production at all. The analysis showed these two molecules—the drug receptor and insulin—were often made together in the same cells, suggesting a coordinated local system. This discovery points to a potential 'intracortical metabolic signaling' network, meaning the brain's outer layer might have its own way of managing energy and signals using these molecules, completely separate from the body's main insulin supply. It's a clue that could help us understand why drugs that target blood sugar sometimes have powerful effects on the brain.

What this means for you:
Specific human brain cells can locally produce insulin and carry a diabetes drug receptor, hinting at a brain-based energy system.
Read the Full Clinical Summary →
View Original Abstract ↓
Aims/hypothesisEmerging evidence suggests that glucagon-like peptide-1 receptor (GLP1R) and insulin (INS), traditionally associated with peripheral metabolic regulation, also exert key functions in the central nervous system. We hypothesised that specific human cortical interneuron subtypes locally express GLP1R and INS, a molecular feature that may be relevant for exploring potential intracortical metabolic signalling mechanisms.MethodsWe analysed single layer 1 GABAergic interneurons microdissected from human cortical tissue using laser capture microdissection. Transcriptomic subtype identification was performed using digital PCR preamplification of LAMP5, SV2C and PRSS12 markers. GLP1R and INS and mRNA copy numbers were quantified using single-cell digital PCR, and spatial expression patterns were validated using RNAscope Hi-Plex in situ hybridisation.ResultsNeurogliaform (LAMP5+, SV2C+, PRSS12–) and rosehip cells (LAMP5+, SV2C+, PRSS12+) exhibited significantly higher GLP1R and INS expression than other LAMP5 interneurons. GLP1R mRNA was found in 44/72 neurogliaform and 18/36 rosehip cells, whereas INS mRNA was detected in 29/72 and 11/36 respectively. No INS expression was detected in other LAMP5 interneurons. Co-expression analysis revealed significant statistical dependency (mutual information = 0.244, p